|
Re: Metabolic management of cancer
Other cell-death assay labs in the US have been testing DCA for several years. However, they've never been overly impressed in it being an active agent.
Are you aware of any clinical trials, even presented at a meeting with an abstract? It's getting to be an old drug by now and all there seems to be are anecdotes, to my knowledge. I can't find a single publication of a clinical trial. Am I missing it?
I understand ChemoFit is not 3D analysis. If they're measuring with flow cytometry, it's got to be single cells. And I don't know exactly about their transport medium they are using.
In cell-based functional profiling assays, polypropylene is the stuff that cell culture plates are made out of. Polypropylene keeps the tumor clusters in a 3D conformation. With typical cell culture plate plastic, the cells would attach and spread out into a 2D conformation.
|